Dr. Widlanski's research emphasizes an eclectic approach to solving biochemical and biomedical problems using a broad array of chemical approaches. This approach includes the design and evaluation of enzyme inhibitors, the elucidation of enzyme reaction mechanisms, the development of new synthetic methods to access important biologically active compound analogs and biological probes, and the study of components of signal transduction pathways, including those associated with a variety of disease states ranging from cancer to HIV. 

Subject areas:

  • Chemical Biology
  • Organic
  • Life
  • Synthesis
Biochemistry, Molecular Biology, Cellular Biochemistry, Molecular Biochemistry, Chemistry
PhD, Harvard University, 1989
MA, Harvard University, 1983
BA, Columbia University, 1982
enzymology medicinal chemistry hiv/aids antivirals chemotherapeutic agents drug design molecular probes enzymes inhibitors nucleic acids proteins and macromolecules steroids gene regulation biomedical research resources, other tissue culture chemical sciences